Z. A. Bredikhina et al. / Tetrahedron: Asymmetry 19 (2008) 1430–1435
1435
15 ml of dry THF was added 1.04 g (12 mmol) of anhydrous LiBr.
The suspension was stirred at room temperature for 2–3 h (moni-
tored by TLC for the disappearance of cyclic sulfate). After the sol-
vent was removed under vacuum, in the resulting residue, 25 ml of
ether and 25 ml of 20% aqueous H2SO4 were added. The hetero-
geneous solution was stirred at 25 °C overnight. After completion
of the reaction, the two layers were separated, and the aqueous
layer was extracted with diethyl ether (3 ꢃ 15 ml). The combined
ether layer was washed with saturated NaHCO3, water and brine,
dried over Na2SO4 and concentrated to give 0.62 g of (R)-3-
(2-cyanophenoxy)-1-bromo-2-propanol, (R)-7, as a slightly yellow
oil. To a solution of crude bromoalcohol (R)-7 in 20 ml of MeOH
anhydrous K2CO3 (1.10 g, 8 mmol) was added at 0 °C. The hetero-
geneous solution was stirred at this temperature for 2 h (moni-
tored by TLC), and then 10 ml of saturated NH4Cl aqueous
solution was added, followed by extraction with CH2Cl2 (4 ꢃ
15 ml). The extracts were washed with water and brine, dried
over Na2SO4 and concentrated to give 0.38 g (86% on the basic of
6) of crude (S)-1,2-epoxy-3-(2-cyanophenoxy)-propane, (S)-8, as
4.2.11.3. Method C. (S)-1,2-Epoxy-3-(2-cyanophenoxy)-propane,
(S)-8 (0.38 g, 2.15 mmol) and 2.3 ml (21 mmol) of ButNH2 were
heated at reflux for 5–7 h. The reaction was monitored by TLC.
After the disappearance of the starting epoxide the mixture was
evaporated to dryness and the residual viscous oil was crystallized
upon standing giving (S)-1-(2-cyanophenoxy)-2-hydroxy-3-tert-
butylaminopropane; (S)-bunitrolol (S)-1 as a free base. Mp 30–
32 °C; ½a 2D0
ꢁ
¼ ꢂ9:0 (c 0.8, EtOH); ½a D20
ꢁ
¼ þ12:3 (c 0.38, H2O) [cf.
lit.9 for (S)-bunitrolol: mp 162 °C; ½a 2D0
ꢁ ¼ ꢂ10:0 (c 1.4, H2O), 60%
ee]. 1H NMR (600 MHz, CDCl3) d 1.13 (s, 9H, CH3), 2.49 (br s, 2H,
OH, NH), 2.79 (dd, J = 12.1, 6.6 Hz; 1H, CH2N), 2.93 (dd, J = 12.1,
4.4 Hz; 1H, CH2N), 3.97–4.01 (m, 1H, CH), 4.12 (d, J = 4.8 Hz, 2H,
CH2O), 7.00–7.02 (m, 2H, Ar), 7.51–7.56 (m, 2H, Ar). 13C NMR
(150.864 MHz, CDCl3): d 30.54 (CH3), 45.75 (NCH2), 51.97 (CMe3),
69.40 (CHOH), 73.22 (OCH2), 103.75 ðC2ArÞ, 114.04 ðCA6rÞ, 117.80
(CN), 122.55 ðCA4rÞ, 135.12 ðCA3rÞ, 135.77 ðC5ArÞ, 162.03 ðCA1rÞ [cf.
lit.9]. The thus obtained (S)-1 was dissolved in ether, and dry HCl
was passed through the solution until saturation was achieved.
The solid hydrochloride was filtered out (yield 87%); after two suc-
cessive crystallizations from EtOH, (S)-1ꢀHCl was isolated in a yield
a white solid; mp 90–91 °C (diethyl ether/methanol), ½a D20
¼
ꢁ
þ18:5 (c 0.5, EtOH), ½a D20
ꢁ
¼ ꢂ5:0 (c 1.0, CHCl3) {lit.20 mp 88–
of 66%; mp 184–186 °C, ½a D20
ꢁ
¼ ꢂ29:6 (c 0.9, EtOH); ½a D20
¼ ꢂ14:7 (c
ꢁ
89 °C, ½a 2D5
ꢁ
¼ þ17:7 (c 1, EtOH); lit.9 gum, ½a D25
ꢁ
¼ þ2:3 (c 2.3,
0.8, H2O).
CHCl3)}.
(R)-1ꢀHCl was obtained from (R)-8 and ButNH2 following the
above-mentioned procedure. (R)-1ꢀHCl: mp 187–189 °C,
½
a 2D0
ꢁ
¼ þ29:2 (c 0.7, EtOH).
4.2.11. (S)-1-(2-Cyanophenoxy)-2-hydroxy-3-tert-butylamino-
propane hydrochloride; (S)-bunitrolol hydrochloride; (S)-1ꢀHCl
4.2.11.1. Method A. A solution of dioxathiolane (2RS,4R)-5 (0.9 g,
3.8 mmol) and ButNH2 (2.8 g, 38 mmol) in DMF (5 ml) was heated
at 60–70 °C for 45 h. After this period, excess amine and DMF were
removed in vacuo, 40 ml of a 1 M solution of NaOH was added, the
mixture was extracted with AcOEt (3 ꢃ 40 ml), and extract was
dried over Na2SO4. After removal of the solvent in vacuo, the resi-
due was dissolved in 15 ml of ether and gaseous HCl was passed
through the resulting solution to give 0.59 g (55%) (S)-1ꢀHCl, mp
Acknowledgements
The authors are indebted to Dr. A.V. Pashagin for chiral chroma-
tography measurements. The authors thank the Russian Fund of
Basic Research for financial support (Grant Nos. 06-03-32508 and
07-03-12070).
References
184–186 °C (EtOH); ½a D20
ꢁ
¼ ꢂ29:7 (c 0.6, EtOH). IR (KBr, cmꢂ1):
1. Mehvar, R.; Brocks, D. R. J. Pharm. Pharm. Sci. 2001, 4, 185–200.
2. Nathanson, J. A. J. Pharmacol. Exp. Ther. 1988, 245, 94–101.
3. (a) Narimatsu, S.; Mizukami, T.; Huang, Y.; Masubuchi, Y.; Suzuki, T. J. Pharm.
Pharmacol. 1996, 48, 1185–1189; (b) Narimatsu, S.; Kato, R.; Horie, T.; Ono, S.;
Tsutsui, M.; Yabusaki, Y.; Ohmori, S.; Kitada, M.; Ichioka, T.; Shimada, N.; Kato,
R.; Ishikawa, T. Chirality 1999, 11, 1–9; (c) Masuda, K.; Tamagake, K.; Katsu, T.;
Torigoe, F.; Saito, K.; Hanioka, N.; Yamano, S.; Yamamoto, S.; Narimatsu, S.
Chirality 2006, 18, 167–176.
4. The Merck Index; O’Neil, M. J., Ed., 14th ed.; Merck and Co.: Whitehouse Station,
NJ, USA, 2006; p 1479.
5. Murakami, H. Top. Curr. Chem. 2007, 269, 273–299.
6. Bredikhin, A.; Bredikhina, Z.; Zakharychev, D.; Akhatova, F.; Krivolapov, D.;
Litvinov, I. Mendeleev Commun. 2006, 16, 245–247.
7. Campo, C.; Llama, E. F.; Bermudez, J. L.; Sinisterra, J. V. Biocatal. Biotransform.
2001, 19, 163–180.
3260 (br, OH); 2927, 2874 ðNH2þÞ; 2227 (CN); 1599, 1580, 1496
(Ar). 1H NMR (600 MHz, CDCl3): d 1.54 (s, 9H, CH3), 3.29 (dd,
J = 18.5, 9.5 Hz; 1H, CH2N), 3.40 (dd, J = 18.5, 8.6 Hz; 1H, CH2N),
4.25 (dd, J = 9.5, 5.1 Hz, 1H, CH2O), 4.29 (dd, J = 9.5, 4.0 Hz, 1H,
1CH2O), 4.72 (m, 1H, CH), 5.50 (s, 1H, OH), 7.03–7.06 (m, C4ArH,
C6ArH), 7.53–7.56 (m, C3ArH, CA5rH), 8.29 (s, 1H, NH), 9.62 (s, 1H,
NH). 13C NMR (150.864 MHz, CDCl3):
d 25.91 (CH3), 45.28
(NCH2), 58.01 (CMe3), 65.58 (CHOH), 70.82 (OCH2), 102.36 ðC2 Þ,
113.04 ðC6ArÞ, 116.27 (CN), 121.50 ðCA4rÞ, 133.43 ðC3ArÞ, 134.50 ðCA5ArrÞ,
160.14 ðC1ArÞ. Anal. Calcd for C14H21ClN2O2: C, 59.89; H, 7.49; N,
9.98; Cl, 12.48. Found: C, 60.07; H, 7.74; N, 9.76; Cl, 12.8.
8. Wang, Z.-M.; Zhang, X.-L.; Sharpless, K. B. Tetrahedron Lett. 1993, 34, 2267–
2270.
4.2.11.2. Method B. The cyclic sulfate opening with tert-butyl
amine was conducted by analogy with a published procedure.22
A solution of cyclic sulfate (R)-6 (255 mg, 1.0 mmol) and ButNH2
(0.11 g, 0.16 ml, 1.5 mmol) in 5 ml THF was stirred at room tem-
perature for 24 h until the disappearance of 6 (TLC). The solution
was then concentrated, and the residue was stirred with 20% aque-
ous H2SO4 (9 ml) and ether (20 ml) for 12 h. Sodium hydroxide pel-
lets were added to the ice-cooled reaction mixture slowly until the
pH >12 was reached. The layers were separated, and the aqueous
layer was extracted with three more portions of AcOEt (30 ml
each) and combined extract was dried over Na2SO4. After the
removal of solvent, the residue was dissolved in PriOH (minimal
amount), and 0.2 ml of concd aqueous HCl was added. White
crystals slowly precipitate during standing. After filtering off and
ether rinsing out 71 mg (25%) of (S)-bunitrolol hydrochloride,
9. Sayyed, I. A.; Thakur, V. V.; Nikalje, M. D.; Dewkar, G. K.; Kotkar, S. P.; Sudalai, A.
Tetrahedron 2005, 61, 2831–2838.
10. Bredikhina, Z. A.; Novikova, V. G.; Zakharychev, D. V.; Bredikhin, A. A.
Tetrahedron: Asymmetry 2006, 17, 3015–3020.
11. Bredikhin, A. A.; Bredikhina, Z. A.; Zakharychev, D. V.; Konoshenko, L. V.
Tetrahedron: Asymmetry 2007, 18, 1964–1970.
12. Zakharychev, D. V.; Lazarev, S. N.; Bredikhina, Z. A.; Bredikhin, A. A. Russ. Chem.
Bull. Int. Ed. 2006, 55, 230–237.
13. Li, Z. J.; Zell, M. T.; Munson, E. J.; Grant, D. J. W. J. Pharm. Sci. 1999, 88, 337–346.
14. Jacques, J.; Collet, A.; Wilen, S. H. Enantiomers, Racemates and Resolutions;
Krieger Publishing Company: Malabar, Florida, 1994. 447 pp.
15. Coquerel, G. Top. Curr. Chem. 2007, 269, 1–51.
16. Dufour, F.; Perez, G.; Coquerel, G. Bull. Chem. Soc. Jpn. 2004, 77, 79–86.
17. Gao, Y.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 7538–7539.
18. Alonso, M.; Riera, A. Tetrahedron: Asymmetry 2005, 16, 3908–3912.
19. He, L.; Byun, H. S.; Bittman, R. J. Org. Chem. 1998, 63, 5696–5699.
20. Nicola, M.; Depaoli, A.; Inglesi, M. Gazz. Chim. Ital. 1990, 120, 393–396.
21. Schaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A.
E.; Furrow, M. E.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 1307–1315.
22. Tomalia, D. A.; Falk, J. C. J. Heterocycl. Chem. 1972, 9, 891–894.
(S)-1ꢀHCl was collected. Mp 184–186 °C (EtOH), ½a D20
¼ ꢂ29:1 (c
ꢁ
0.9, EtOH).